Related Experiment Videos

Re-evaluation of chorioamnionitis and funisitis with a special reference to subacute chorioamnionitis

Makiko Ohyama1, Yasufumi Itani, Michiko Yamanaka

  • 1Division of Neonatology, Obstetrics, and Pathology, Kanagawa Children's Medical Center, Yokohama City, Japan.

Human Pathology
|April 17, 2002
PubMed

Insights

Subacute chorioamnionitis (SCAM) is a distinct placental condition. It serves as a key predictor for chronic lung disease (CLD) in premature infants, differentiating it from acute chorioamnionitis.

Area of Science:

  • Perinatal pathology
  • Neonatal medicine
  • Obstetrics

Background:

  • Chorioamnionitis is inflammation of the fetal membranes.
  • Acute chorioamnionitis (ACAM) is a well-recognized condition.
  • The prognostic significance of prolonged chorionic plate inflammation was unclear.

Purpose of the Study:

  • To establish subacute chorioamnionitis (SCAM) as a distinct entity.
  • To differentiate SCAM from ACAM.
  • To evaluate SCAM as a prognostic indicator for chronic lung disease (CLD) in preterm infants.

Main Methods:

  • Analysis of 90 placentas from preterm infants (23-32 weeks gestation) with stage-3 chorioamnionitis.
  • Classification of placentas into SCAM, ACAM, and subacute necrotizing funisitis (SNF) groups.
  • Comparison with 53 control placentas without chorioamnionitis; logistic regression analysis of clinical and histological variables.

Main Results:

  • Subacute chorioamnionitis (SCAM) was identified in 49 placentas.
  • Amniotic necrosis (AN) and low birthweight were significant risk factors for CLD.
  • Patients with SCAM, particularly those with AN, showed high susceptibility to CLD.

Conclusions:

  • Subacute chorioamnionitis (SCAM) is a distinct pathological entity.
  • SCAM, especially with associated amniotic necrosis, is a significant prognostic indicator for CLD.
  • Differentiating SCAM from ACAM is crucial for predicting infant outcomes.

Related Concept Videos